Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
European Journal of Heart Failure|January 28, 2014
Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal modelsCho-Kai Wu, Yi-Chih Wang, Jen-Kuang Lee, et al.Annals of Medicine|August 28, 2024
Role of calcification in J-CTO score: a viewpoint of intraplaque guidewire tracking techniquesShih-Chi Liu, Chien-Lin Lee, Jen-Fang Cheng, et al.Journal of the American Heart Association|April 2, 2019
Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese PatientsDeepa M Gopal, Nir Ayalon, Yi-Chih Wang, et al.International Journal of Cardiology|September 1, 2015
Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal diseaseLi-Ting Ho, Lian-Yu Lin, Yao-Hsu Yang, et al.Journal of Personalized Medicine|March 25, 2022
The Sequential Change in Left Ventricular Function among Various Cardiovascular Diseases: A 12-Year StudySheng-Nan Chang, Jou-Wei Lin, Yi-Chih Wang, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2011
The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkersYen-Wen Wu, Hsian-Li Kao, Chi-Lun Huang, et al.Heart Rhythm|April 16, 2014
Renin-angiotensin system gene polymorphisms predict the risk of stroke in patients with atrial fibrillation: a 10-year prospective follow-up studyChia-Ti Tsai, Sheng-Nan Chang, Shu-Hsuan Chang, et al.The American Journal of Cardiology|September 29, 2025
Application of the J-CTO Score to Recanalization for In-Stent Chronic Total OcclusionsChieh-Yu Chen, Chi-Hung Huang, Jen-Fang Cheng, et al.Clinical Science (London, England : 1979)|February 2, 2017
Genome-wide methylation profiles in coronary artery ectasiaTzu-Pin Lu, Nai-Chen Chuang, Chin-Yu Cheng, et al.International Journal of Cardiology|September 2, 2015
Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapyYi-Wei Chung, Yao-Hsu Yang, Cho-Kai Wu, et al.Pageof 8